









Markets
/
Stocks
/
nasdaq-iinn
/

Inspira Technologies Oxy BHN Ltd

IINN

0.908USD

+0.029+3.25%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

26.02MMarket Cap

LossP/E TTM



Inspira Technologies Oxy BHN Ltd

0.908

+0.029+3.25%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Inspira Technologies Oxy BHN Ltd

Currency: USD Updated: 2025-10-27

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inspira Technologies Oxy BHN Ltd's Score

Industry at a Glance

Industry Ranking

158 / 204

Overall Ranking

464 / 4682

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

5.000

Target Price

+468.50%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inspira Technologies Oxy BHN Ltd Highlights

StrengthsRisks

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

Fairly Valued

The company’s latest PE is -2.32, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 1.12M shares, increasing 38.23% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.50.

Financial Health

Currency: USD Updated: 2025-10-27

There is no financial score for this company; the Healthcare Equipment & Supplies industry's average is 7.47.

Score

Industry at a Glance

Previous score

0.00

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

Inspira Technologies Oxy BHN Ltd's Company Valuation

Currency: USD Updated: 2025-10-27

The company’s current valuation score is 6.73, which is lower than the Healthcare Equipment & Supplies industry's average of 7.16. Its current P/E ratio is -2.32, which is -69.02% below the recent high of -0.72 and -591.52% above the recent low of -16.06.

Score

Industry at a Glance

Previous score

6.73

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 158/204

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-27

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.72. The average price target for Inspira Technologies Oxy BHN Ltd is 5.00, with a high of 5.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

5.000

Target Price

+468.50%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Inspira Technologies Oxy BHN Ltd

IINN

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-27

The company’s current price momentum score is 6.47, which is lower than the Healthcare Equipment & Supplies industry's average of 7.16. Sideways: Currently, the stock price is trading between the resistance level at 1.24 and the support level at 0.96, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.80

Change

-0.33

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.039

Sell

RSI(14)

31.860

Neutral

STOCH(KDJ)(9,3,3)

14.830

Neutral

ATR(14)

0.060

High Vlolatility

CCI(14)

-102.125

Sell

Williams %R

82.394

Oversold

TRIX(12,20)

-0.961

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

0.907

Buy

MA10

0.985

Sell

MA20

1.061

Sell

MA50

1.151

Sell

MA100

1.168

Sell

MA200

0.942

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-27

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.37. The latest institutional shareholding proportion is 3.93%, representing a quarter-over-quarter decrease of 71.79%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Ben-Noon (Dagi Shahar)

1.61M

+393.94%

Armistice Capital LLC

971.82K

Hayon (Joe)

628.54K

+0.29%

UBS Financial Services, Inc.

65.28K

+89.79%

Corsair Capital Management, L.P.

25.00K

HRT Financial LP

19.54K

+11.92%

Laidlaw Wealth Management LLC

13.50K

Jane Street Capital, L.L.C.

11.75K

Equitable Holdings, Inc.

10.00K

Geode Capital Management, L.L.C.

2.92K

Risk Assessment

Currency: USD Updated: 2025-10-27

There is no risk assessment score for the company; the Healthcare Equipment & Supplies industry's average is 4.64. The company's beta value is 2.30. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.